Medicure Inc. (CVE:MPH – Get Free Report) shares reached a new 52-week low during trading on Tuesday . The stock traded as low as C$0.82 and last traded at C$0.82, with a volume of 500 shares changing hands. The stock had previously closed at C$0.83.
Medicure Price Performance
The company has a market capitalization of C$8.56 million, a price-to-earnings ratio of -3.28 and a beta of 0.90. The company has a current ratio of 1.87, a quick ratio of 1.29 and a debt-to-equity ratio of 2.06. The company has a 50 day moving average price of C$0.90 and a 200 day moving average price of C$0.97.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Further Reading
- Five stocks we like better than Medicure
- What is a Bond Market Holiday? How to Invest and Trade
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Short Selling: How to Short a Stock
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- How to Use the MarketBeat Excel Dividend Calculator
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
